Pityriasis lichenoides is a rare inflammatory skin disease classified as a reaction to various triggers, including infections, stress, and possibly autoimmune processes. The disease is characterized by the presence of papules that may coalesce to form plaques. The papules are usually reddish-brown in color and covered with bran-like scales, which can lead to itching and discomfort. There are two main forms of this disease: acute and chronic. The acute form can be symptomatic, while the chronic form is often more latent. Despite its rarity, pityriasis lichenoides requires a careful approach to diagnosis and treatment, as it can have a significant impact on the quality of life of patients.
History of the disease and interesting historical facts
Pityriasis lichenoides was first described in medical literature at the beginning of the 20th century, but similar skin lesions had been mentioned before. In 1891, the famous dermatologist Adolf Rose described symptoms similar to pityriasis lichenoides. Interestingly, this condition has been perceived differently in different cultures and eras, due to its rarity and incomplete understanding of its pathogenesis. In the 1950s, the first version of the classification was proposed, which distinguished various clinical forms of the disease. Over the past decades, a lot of data has accumulated that improve our understanding of the etiology and pathogenesis of this dermatological problem.
Epidemiology
Statistics on the occurrence of pityriasis lichenoides indicate its low prevalence. The disease is most often found in young people aged 10 to 30 years. According to various sources, the incidence varies from 0.2 to 3 cases per 100,000 population per year. The pathology can be observed in both men and women, but some studies note a slight predisposition of men to more severe forms of the disease. The use of high-quality dermatological technologies and diagnostic procedures, as well as a higher level of awareness among doctors, have contributed to improved diagnosis and recording of cases of this disease.
Genetic predisposition to this disease
Studies show that genetic predisposition may play a significant role in the development of pityriasis lichenoides. Some authors point to the presence of polymorphisms in genes responsible for the immune response, such as HLA genes. Associations with ALR and MG alleles have also been found. Moreover, mutations in certain genes, such as IL-10 and TNF-α, may increase the risk of developing the disease, which is confirmed by data on increased susceptibility among relatives of patients. However, the mechanisms contributing to the development of this dermatosis are not fully understood and require further research.
Risk factors for the development of this disease
There are several risk factors that contribute to the development of pityriasis lichenoides. These include:
- Infectious diseases: viral and bacterial infections such as herpes or mycoplasma infection.
- Immune disorders: Disorders in the immune system may predispose to this disease.
- Chemical factors: Contact with certain chemicals, such as insecticides or cleaning products, can cause acute exacerbation of the disease.
- Physical stress: Emotional or physical stress can trigger symptoms of the disease.
- Medications: Some medications, such as antibiotics or psoriasis medications, can cause flare-ups.
Diagnosis of this disease
Diagnosis of pityriasis lichenoides is based on clinical examination and analysis of the patient's medical history. The main symptoms include:
- Papules that may be red or brown in color.
- Itching, which can range from mild to moderate.
- Bran-like scales that cover the surface of the papules.
Laboratory tests may include a complete blood count and specific tests to identify infectious agents. Radiological examinations are not mandatory, but may be performed if there are comorbidities. The differential diagnosis should exclude conditions such as psoriasis, dermatitis, and other dermatoses. Importantly, a skin biopsy can provide additional information about cellular infiltration and help in the final diagnosis.
Treatment
Treatment of pityriasis lichenoides involves several approaches, such as:
- General treatment: In some cases, limiting exposure to triggers and following a healthy lifestyle is enough.
- Pharmacological treatment: Drugs such as corticosteroids and cyclosporine may be prescribed to reduce inflammation.
- Surgical treatment: Extreme cases may require removal of affected areas of skin.
- Other treatments: Phototherapy and the use of retinoids may also be effective in treating this condition.
List of drugs used to treat this disease
Medications used to treat pityriasis lichenoides include:
- Corticosteroids (topical and systemic).
- Cyclosporine.
- Retinoids.
- Ultraviolet therapy (eg, narrowband UVB phototherapy).
Disease monitoring
Monitoring of patients with pityriasis lichenoides includes regular examination by a dermatologist and assessment of the dynamics of the disease. The prognosis is favorable in most cases, especially with early treatment. Complications may develop in the absence of adequate control and may include secondary infections or the development of more severe forms of dermatosis.
Age-related features of the disease
Pityriasis lichenoides can occur at any age, but the highest incidence is seen in adolescents and young adults. In children, the disease often has a less severe course, while in adults it may manifest itself more clearly and require longer treatment. In older patients, pityriasis lichenoides is less common, but may be associated with concomitant chronic diseases.
Questions and Answers
- What is pityriasis lichenoides? This is a rare skin condition characterized by papules and plaques that may be itchy.
- What are the main symptoms of the disease? The main symptoms include redness, itching, and the formation of papules with bran-like scales.
- What factors can provoke an exacerbation of the disease? Infections, stress, contact with chemicals and some medications.
- How is pityriasis lichenoides treated? Treatment may include corticosteroids, phototherapy, and other anti-inflammatory medications.
- What is the prognosis for the disease? In most cases, the prognosis is favorable, but monitoring the patient's condition is necessary to prevent complications.
